{"id":"NCT02100475","sponsor":"Novo Nordisk A/S","briefTitle":"A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification","officialTitle":"A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification (DUAL™ - Intensification)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-04","primaryCompletion":"2015-04","completion":"2015-04","firstPosted":"2014-04-01","resultsPosted":"2017-01-20","lastUpdate":"2017-01-20"},"enrollment":31,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"insulin degludec/liraglutide","otherNames":[]},{"type":"DRUG","name":"insulin aspart","otherNames":[]}],"arms":[{"label":"Insulin degludec/liraglutide + Metformin","type":"EXPERIMENTAL"},{"label":"Insulin degludec/liraglutide + Insulin Aspart + Metformin","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is conducted globally. The aim of the trial is to compare sequential addition of insulin aspart versus further dose increase with insulin degludec/liraglutide in subjects with type 2 diabetes mellitus, previously treated with insulin degludec/liraglutide and metformin and in need of further intensification.\n\nThis is an extension to trial NN9068-3952, NCT01952145 (DUAL™ V).","primaryOutcome":{"measure":"Change From Baseline in HbA1c (Glycosylated Haemoglobin)","timeFrame":"Week 0, week 26","effectByArm":[{"arm":"IDegLira","deltaMin":-0.43,"sd":0.94},{"arm":"IDegLira + IAsp","deltaMin":-0.14,"sd":1.09}],"pValues":[{"comp":"OG000 vs OG001","p":"0.427"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":60,"countries":["United States","Argentina","Australia","Greece","Hungary","Mexico","Russia","Slovakia","South Africa","Spain"]},"refs":{"pmids":[],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":16},"commonTop":["Back pain","Lipase increased","Abdominal pain","Amylase increased","Anaemia"]}}